Table 1. Model peptides used to study APL function.
Peptide | MHC | Role described or differential T cell function elicited by APLs | References |
---|---|---|---|
Murine (in vitro) | |||
Hb(64 – 76) | I-Ek | IL-4 production and T cell-B cell collaboration (as assessed by B cell proliferation and Ig production) by Th2 clones; cytolytic activity, upregulation of CD25 and of LFA-1 and increased cell volume by Th1 clones; anergy in Th1 and Th2 clones | 1, 10, 28, 37 |
PCC(88 – 104) | I-Ek | Inhibition of IL-2 production by Th1 clones; upregulation of CD25 and increased cell volume; negative selection of DP thymocytes | 12, 13 |
OVA(257 – 264) | Kb | TCR antagonism of cytolysis, cytokine production, Ca2+ flux and serine esterase release in Th1 clones; induction of positive selection of thymocytes | 4, 6, 48 |
LCMV GP(33 – 41) | H-2Db | Induction of positive selection of thymocytes and cytotoxic T cell memory | 49, 197 |
MCC(88 – 103) | H-2Ek | Inhibition of IL-2 production, upregulation of CD25 and increased cell volume; negative selection of DP thymocytes | 13 |
huColIV | I-As, I-Ab | Differential IFN-γ and IL-4 production and T cell-B cell collaboration (as assessed by Ig production) | 11 |
Human (in vitro) | |||
HA(307 – 319) | HLA-DR1 | TCR antagonism causing reduced proliferation of Th1 clones | 3 |
TT(830 – 843) | HLA-DR1 | TCR antagonism causing reduced proliferation of Th1 clones | 3 |
HA(307 – 319) | HLA-DR5 | TCR antagonism as antigen-specific process | 5 |
HBc(18 – 27) | HLA-A2 | Naturally occurring TCR antagonists: antagonism of cytolytic function | 64 |
PCC = Pigeon cytochrome C; LCMV-GP = lymphocytic choriomeningitis virus-Gag protein; DP = double positive; MCC = moth cytochrome C; HA = influenza hemagglutinin; TT = tetanus toxoid; HBc = hepatitis B virus core; huColIV = human collagen IV.